Home/Filings/4/0001213900-16-012632
4//SEC Filing

Actinium Pharmaceuticals, Inc. 4

Accession 0001213900-16-012632

$ATNMCIK 0001388320operating

Filed

Apr 17, 8:00 PM ET

Accepted

Apr 18, 5:26 PM ET

Size

5.5 KB

Accession

0001213900-16-012632

Insider Transaction Report

Form 4
Period: 2016-04-15
CICIC DRAGAN
COO and CMO
Transactions
  • Award

    Options to purchase common stock

    2016-04-15$1.99/sh+50,000$99,50050,000 total
    Exercise: $1.99Exp: 2026-04-15Common Stock (50,000 underlying)
Footnotes (1)
  • [F1]Pursuant to the terms of the company's Amended and Restated 2013 Stock Plan, 2% of the options shall vest each month from the date of grant.

Issuer

Actinium Pharmaceuticals, Inc.

CIK 0001388320

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001388320

Filing Metadata

Form type
4
Filed
Apr 17, 8:00 PM ET
Accepted
Apr 18, 5:26 PM ET
Size
5.5 KB